ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,964Medicare Part D Prescriptions Filled, Including Refills

Rank: 207 out of 780

$585K Total Retail Price of All Prescriptions

Rank: 240 out of 780

364 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 364 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

47% of this provider’s 364 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 8,075 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,046 519 S3 1 1
LEVOTHYROXINE SODIUM 360 262 2 5
OMEPRAZOLE 331 197 3 3
LOVASTATIN 318 181 4 47
LISINOPRIL 315 218 5 6
POTASSIUM CHLORIDE 310 242 6 11
FUROSEMIDE 303 231 7 7
HYDROCHLOROTHIAZIDE 241 138 8 10
WARFARIN SODIUM 240 206 9 24
CLONIDINE HCL 236 140 10 28
SIMVASTATIN 216 144 11 2
TRAMADOL HCL 210 105 12 15
ZOLPIDEM TARTRATE 209 83 13 17
METFORMIN HCL 174 101 14 8
AMLODIPINE BESYLATE 174 130 14 4
MELOXICAM 167 83 16 16
IBUPROFEN 155 45 17 93
CARVEDILOL 154 131 18 14
CIPROFLOXACIN HCL 145 66 19 49
PANTOPRAZOLE SODIUM 144 73 20 25
ESCITALOPRAM OXALATE 142 56 21 61
ATORVASTATIN CALCIUM 141 110 22 12
GLIPIZIDE 139 106 23 74
MIRTAZAPINE 130 104 24 58
RISPERIDONE 127 77 25 98
CITALOPRAM HBR 127 79 25 23
NEXIUM 124 55 27 22
METOPROLOL TARTRATE 122 86 28 19
EXELON 120 110 29 132
GABAPENTIN 114 38 30 13
NAMENDA 109 98 31 46
DIGOXIN 101 81 32 56
AMOXICILLIN 98 56 33 99
ATENOLOL-CHLORTHALIDONE 94 69 34 182
CLOPIDOGREL 94 82 34 34
CYCLOBENZAPRINE HCL 93 44 R 36 42
LYRICA 90 35 37 52
FLUOXETINE HCL 88 36 38 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 32 39 26
METOPROLOL SUCCINATE 80 70 40 20
ATENOLOL 80 55 40 21
CYMBALTA 79 42 42 51
TRAZODONE HCL 76 20 43 35
GEMFIBROZIL 75 38 44 104
MECLIZINE HCL 75 51 44 83
VENTOLIN HFA 74 18 46 91
PROMETHAZINE HCL 71 16 R 47 66
LANTUS 71 46 47 71
PLAVIX 67 58 49 45
FENTANYL 67 0 S2 49 107
GLIPIZIDE ER 63 63 51 109
FENOFIBRATE 61 43 52 63
AMITRIPTYLINE HCL 61 46 R 52 48
SERTRALINE HCL 60 56 54 27
INDAPAMIDE 59 57 55 190
PREMARIN 59 0 R 55 110
BUMETANIDE 57 35 57 96
QUETIAPINE FUMARATE 53 51 58 81
ADVAIR DISKUS 51 33 59 68
DIVALPROEX SODIUM 50 50 60 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.